{"id":4485,"date":"2025-03-31T18:12:09","date_gmt":"2025-03-31T18:12:09","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/zotepine-txt\/"},"modified":"2025-03-31T18:12:09","modified_gmt":"2025-03-31T18:12:09","slug":"zotepine-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/zotepine-txt\/","title":{"rendered":"Zotepine.txt"},"content":{"rendered":"<p><H3>  CLINICAL USE <\/H3>  Treatment of schizophrenia <H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3> 25\u2013100 mg 3 times a day <H3>  PHARMACOKINETICS    <\/H3> <LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : 331.9 <\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : 97 <\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : &lt;0.1 (40% as metabolites) <\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp : 50\u2013168 <\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp : 14\/Increased <H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4> <LI> 20 to 50  &amp;nbsp &amp;nbsp : 25 mg twice daily increasing to 75 mg twice daily <LI> 10 to 20  &amp;nbsp &amp;nbsp : 25 mg twice daily increasing to 75 mg twice daily <LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : 25 mg twice daily increasing to 75 mg twice daily <H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3> <LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp: Unknown dialysability. Dose as GFR &lt;10 mL\/min <\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Unknown dialysability. Dose as GFR &lt;10 mL\/min <LI>HDF\/high flux  &amp;nbsp : Unknown dialysability. Dose as GFR &lt;10 mL\/min <LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp: Unknown dialysability. Dose as GFR 10 to 20   mL\/min <H3> IMPORTANT DRUG INTERACTIONS  <\/H3> Potentially hazardous interactions with other drugs\n<li>     Anaesthetics: enhanced hypotensive effect\n<li>Analgesics: increased risk of convulsions   with tramadol; enhanced hypotensive and sedative effects with opioids\n<li>Antidepressants: concentration increased   by fluoxetine; concentration of tricyclics possibly increased\n<li>Anti-epileptics: antagonism, as convulsive   threshold lowered\n<li>Antimalarials: avoid concomitant use with   artemether\/lumefantrine\n<li>Antivirals:  concentration possibly   increased by ritonavir Anxiolytics and hypnotics: enhanced   sedative effects; concentration increased by diazepam\n<li>Sibutramine: increased risk of CNS   toxicity \u2013 avoid concomitant use <H3> ADMINISTRATION  <\/H3> <H4> Reconstition<\/H4> \u2013 <H4>  Route  <\/H4> Oral   <H4>  Rate of Administration  <\/H4> \u2013 <H4>Comments<\/H4> \u2013 <H4>  OTHER INFORMATION  <\/H4> Do not use if there is a history of   nephrolithiasis Occasionally can increase creatinine levels   Undergoes extensive first pass metabolism   .<br \/>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Treatment of schizophrenia DOSE IN NORMAL RENAL FUNCTION<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-4485","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=4485"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4485\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=4485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=4485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=4485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}